Yvonne Maldonado Selected Research

Yvonne Maldonado Research Topics

Disease

13	Poliomyelitis (Polio) 01/2022 - 08/2007
11	COVID-19 11/2023 - 01/2021
6	Infections 10/2022 - 01/2012
3	Disease Progression 10/2022 - 12/2021
3	HIV Infections (HIV Infection) 10/2018 - 01/2012
3	Measles 07/2004 - 07/2003
2	Inflammation (Inflammations) 01/2022 - 12/2021
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 07/2014
2	Mumps 07/2004 - 07/2003
1	Coinfection 10/2023
1	Fever (Fevers) 01/2023
1	Retinal Diseases 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Sepsis (Septicemia) 01/2020
1	Short Bowel Syndrome 01/2020
1	Growth Disorders 12/2019
1	acute flaccid myelitis 10/2018
1	Paralysis (Palsy) 10/2018
1	Persistent Infection 10/2018
1	Toxoplasmosis 06/2017
1	Intussusception 07/2015
1	Staphylococcal Infections 01/2013
1	Drug-Related Side Effects and Adverse Reactions 08/2006
1	Neutropenia 08/2006
1	Mastitis 10/2005
1	Diarrhea 09/2005
1	Rotavirus Infections 09/2005
1	Rubella (German Measles) 07/2004

Drug/Important Bio-Agent (IBA)

23	VaccinesIBA 01/2023 - 01/2004
4	Immunoglobulin G (IgG)IBA 01/2022 - 06/2017
4	AntibodiesIBA 01/2022 - 07/2004
4	Nevirapine (Viramune)FDA Link 12/2019 - 08/2006
4	Measles VaccineIBA 08/2012 - 07/2003
3	BNT162 VaccineIBA 01/2023 - 01/2022
3	Messenger RNA (mRNA)IBA 10/2022 - 12/2021
2	favipiravirIBA 11/2022 - 07/2021
2	CytokinesIBA 10/2022 - 01/2022
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 12/2021
2	COVID-19 VaccinesIBA 01/2022 - 12/2021
2	peginterferon lambda-1aIBA 07/2021 - 01/2021
2	Oral Poliovirus Vaccine (Sabin Vaccine)IBA 10/2018 - 08/2007
2	Immunoglobulin M (IgM)IBA 10/2018 - 06/2017
2	Rotavirus VaccinesIBA 07/2015 - 09/2005
1	nirmatrelvir and ritonavir drug combinationIBA 11/2023
1	Hepatitis B e AntigensIBA 10/2023
1	Blood Proteins (Serum Proteins)IBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	IgG Receptors (Fc gamma RI)IBA 01/2022
1	Attenuated VaccinesIBA 01/2022
1	mRNA VaccinesIBA 12/2021
1	Viral RNAIBA 07/2021
1	Interferon LambdaIBA 01/2021
1	Complement System Proteins (Complement)IBA 10/2018
1	Methicillin (Metin)FDA Link 01/2013
1	Inactivated VaccinesIBA 01/2012
1	CytosineIBA 08/2007
1	UracilIBA 08/2007
1	EnzymesIBA 08/2007
1	NucleotidesIBA 08/2007
1	RNA (Ribonucleic Acid)IBA 10/2005
1	4-O-carboxymethylascochlorinIBA 07/2004
1	Viral ProteinsIBA 01/2004
1	Peptides (Polypeptides)IBA 01/2004
1	Proteins (Proteins, Gene)FDA Link 01/2004
1	AntigensIBA 01/2004
1	Antiviral Agents (Antivirals)IBA 07/2003
1	Neutralizing AntibodiesIBA 07/2003
1	Mumps Vaccine (Vaccine, Mumps)IBA 07/2003
1	Interferon-gamma (Interferon, gamma)IBA 07/2003

Therapy/Procedure

2	Therapeutics 01/2021 - 08/2012
2	Art Therapy 07/2014 - 03/2014
1	Aftercare (After-Treatment) 11/2023
1	Ventriculoperitoneal Shunt 01/2022
1	Home Parenteral Nutrition 01/2020
1	Highly Active Antiretroviral Therapy (HAART) 01/2018
1	Length of Stay 01/2013